Epigenetic and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary Syndrome
- PMID: 26975253
- PMCID: PMC4791632
- DOI: 10.1038/srep22883
Epigenetic and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary Syndrome
Erratum in
-
Erratum: Epigenetic and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary Syndrome.Sci Rep. 2016 May 9;6:25321. doi: 10.1038/srep25321. Sci Rep. 2016. PMID: 27157924 Free PMC article. No abstract available.
Abstract
Genetic and epigenetic factors may predispose women to polycystic ovary syndrome (PCOS), a common heritable disorder of unclear etiology. Here we investigated differences in genome-wide gene expression and DNA methylation in adipose tissue from 64 women with PCOS and 30 controls. In total, 1720 unique genes were differentially expressed (Q < 0.05). Six out of twenty selected genes with largest expression difference (CYP1B1, GPT), genes linked to PCOS (RAB5B) or type 2 diabetes (PPARG, SVEP1), and methylation (DMAP1) were replicated in a separate case-control study. In total, 63,213 sites (P < 0.05) and 440 sites (Q < 0.15) were differently methylated. Thirty differentially expressed genes had corresponding changes in 33 different DNA methylation sites. Moreover, a total number of 1913 pairs of differentially expressed "gene-CpG" probes were significantly correlated after correction for multiple testing and corresponded with 349 unique genes. In conclusion, we identified a large number of genes and pathways that are affected in adipose tissue from women with PCOS. We also identified specific DNA methylation pathways that may affect mRNA expression. Together, these novel findings show that women with PCOS have multiple transcriptional and epigenetic changes in adipose tissue that are relevant for development of the disease.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4791632/bin/srep22883-f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4791632/bin/srep22883-f2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4791632/bin/srep22883-f3.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4791632/bin/srep22883-f4.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4791632/bin/srep22883-f5.gif)
Similar articles
-
DNA methylation in the pathogenesis of polycystic ovary syndrome.Reproduction. 2019 Jul;158(1):R27-R40. doi: 10.1530/REP-18-0449. Reproduction. 2019. PMID: 30959484 Review.
-
Transcriptional and Epigenetic Changes Influencing Skeletal Muscle Metabolism in Women With Polycystic Ovary Syndrome.J Clin Endocrinol Metab. 2018 Dec 1;103(12):4465-4477. doi: 10.1210/jc.2018-00935. J Clin Endocrinol Metab. 2018. PMID: 30113663
-
[Epigenetics of polycystic ovary syndrome].Rev Med Chil. 2017 Jul;145(7):907-915. doi: 10.4067/s0034-98872017000700907. Rev Med Chil. 2017. PMID: 29182200 Review. Spanish.
-
Comprehensive analysis of genome-wide DNA methylation across human polycystic ovary syndrome ovary granulosa cell.Oncotarget. 2016 May 10;7(19):27899-909. doi: 10.18632/oncotarget.8544. Oncotarget. 2016. PMID: 27056885 Free PMC article.
-
Genome-wide screen of ovary-specific DNA methylation in polycystic ovary syndrome.Fertil Steril. 2015 Jul;104(1):145-53.e6. doi: 10.1016/j.fertnstert.2015.04.005. Epub 2015 May 5. Fertil Steril. 2015. PMID: 25956362
Cited by
-
Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice.Cells. 2024 May 8;13(10):802. doi: 10.3390/cells13100802. Cells. 2024. PMID: 38786026 Free PMC article.
-
Epigallocatechin Gallate for the Treatment of Benign and Malignant Gynecological Diseases-Focus on Epigenetic Mechanisms.Nutrients. 2024 Feb 17;16(4):559. doi: 10.3390/nu16040559. Nutrients. 2024. PMID: 38398883 Free PMC article. Review.
-
Administration of adipose-derived mesenchymal stem cell conditioned medium improves ovarian function in polycystic ovary syndrome rats: involvement of epigenetic modifiers system.J Ovarian Res. 2023 Dec 15;16(1):238. doi: 10.1186/s13048-023-01317-9. J Ovarian Res. 2023. PMID: 38102694 Free PMC article.
-
An Evolutionary Model for the Ancient Origins of Polycystic Ovary Syndrome.J Clin Med. 2023 Sep 22;12(19):6120. doi: 10.3390/jcm12196120. J Clin Med. 2023. PMID: 37834765 Free PMC article.
-
Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome.Biomedicines. 2023 May 28;11(6):1567. doi: 10.3390/biomedicines11061567. Biomedicines. 2023. PMID: 37371662 Free PMC article. Review.
References
-
- Norman R. J., Dewailly D., Legro R. S. & Hickey T. E. Polycystic ovary syndrome. Lancet 370, 685–697 (2007). - PubMed
-
- Lim S. S., Davies M. J., Norman R. J. & Moran L. J. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 18, 618–637 (2012). - PubMed
-
- Hickey T. E., Legro R. S. & Norman R. J. Epigenetic modification of the X chromosome influences susceptibility to polycystic ovary syndrome. J Clin Endocrinol Metab 91, 2789–2791 (2006). - PubMed
-
- Moran L. J., Noakes M., Clifton P. M., Norman R. J. & Fenech M. F. Genome instability is increased in lymphocytes of women with polycystic ovary syndrome and is correlated with insulin resistance. Mutat Res 639, 55–63 (2008). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical